Safe and Sensitive Antiviral Screening Platform Based on Recombinant Human Coronavirus OC43 Expressing the Luciferase Reporter Gene

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2016-07-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.00814-16PMID 27381385PMCID PMC4997878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design

  2016cited by this paper
• DEAD-box RNA helicase DDX3X inhibits DENV replication via regulating type one interferon pathway.

  2015cited by this paper
• A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins

  2015cited by this paper
• Oral Ribavirin for the Treatment of Noninfluenza Respiratory Viral Infections

  2015cited by this paper
• Dynamic Interaction of Stress Granules, DDX3X, and IKK-α Mediates Multiple Functions in Hepatitis C Virus Infection

  2015cited by this paper
• The ns12.9 Accessory Protein of Human Coronavirus OC43 Is a Viroporin Involved in Virion Morphogenesis and Pathogenesis

  2015cited by this paper
• Prevalence and Genetic Diversity Analysis of Human Coronavirus OC43 among Adult Patients with Acute Respiratory Infections in Beijing, 2012

  2014cited by this paper
• Antigenic structures stably expressed by recombinant TGEV-derived vectors

  2014cited by this paper
• Molecular pathology of emerging coronavirus infections

  2014cited by this paper
• Human coronaviruses: Viral and cellular factors involved in neuroinvasiveness and neuropathogenesis

  2014cited by this paper
• A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs

  2014cited by this paper
• Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture

  2014cited by this paper
• Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2014)

  2014cited by this paper
• Coronavirus Replicase-Reporter Fusions Provide Quantitative Analysis of Replication and Replication Complex Formation

  2014cited by this paper
• Molecular cloning, functional characterization and antiviral activity of porcine DDX3X.

  2014cited by this paper
• Overlapping and Distinct Molecular Determinants Dictating the Antiviral Activities of TRIM56 against Flaviviruses and Coronavirus

  2014cited by this paper
• Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin

  2013cited by this paper
• Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2013)

  2013cited by this paper
• A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV

  2013cited by this paper
• Identification of Five Interferon-Induced Cellular Proteins That Inhibit West Nile Virus and Dengue Virus Infections

  2010cited by this paper
• Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication

  2010cited by this paper
• Discovery of Insect and Human Dengue Virus Host Factors

  2009cited by this paper
• Inhibition of Protein Kinase R Activation and Upregulation of GADD34 Expression Play a Synergistic Role in Facilitating Coronavirus Replication by Maintaining De Novo Protein Synthesis in Virus-Infected Cells

  2009cited by this paper
• Coronaviruses post-SARS: update on replication and pathogenesis

  2009cited by this paper
• Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice

  2009cited by this paper
• Towards construction of viral vectors based on avian coronavirus infectious bronchitis virus for gene delivery and vaccine development

  2009cited by this paper
• Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKε‐mediated IRF activation

  2008cited by this paper
• The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response

  2008cited by this paper
• Genome-scale RNAi screen for host factors required for HIV replication.

  2008cited by this paper
• RNA interference screen for human genes associated with West Nile virus infection

  2008cited by this paper
• Drosophila RNAi screen identifies host genes important for influenza virus replication

  2008cited by this paper
• Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK

  2007cited by this paper
• Renilla Luciferase as a Reporter to Assess SARS-CoV mRNA Transcription Regulation and Efficacy of ANTI-SARS-CoV Agents

  2006cited by this paper
• Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice

  2006cited by this paper
• Recovery of a Neurovirulent Human Coronavirus OC43 from an Infectious cDNA Clone

  2006cited by this paper
• Treatment and vaccines for severe acute respiratory syndrome

  2005cited by this paper
• Coronaviruses as Vectors: Stability of Foreign Gene Expression

  2005cited by this paper
• Coronavirus Spike Glycoprotein, Extended at the Carboxy Terminus with Green Fluorescent Protein, Is Assembly Competent

  2004cited by this paper
• In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine

  2004cited by this paper
• Human Respiratory Coronavirus OC43: Genetic Stability and Neuroinvasion

  2004cited by this paper
• Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function.

  2004cited by this paper
• Expression of reporter genes from the defective RNA CD-61 of the coronavirus infectious bronchitis virus.

  2000cited by this paper
• The International Committee on Taxonomy of Viruses

  1995cited by this paper
• Characterization of the nonstructural and spike proteins of the human respiratory coronavirus OC43: comparison with bovine enteric coronavirus.

  1993cited by this paper
• Growth in suckling-mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease.

  1967cited by this paper
• A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

  1938cited by this paper

• A yeast-based reverse genetics system to generate HCoV-OC43 reporter viruses encoding an eighth subgenomic RNA

  2025influential citation
• High durability virucidal coatings from calcium hydroxide–polyurethane hybrid with efficacy against Human-CoronaVirus OC43-RLuc and 229E-Rluc

  2025cites this paper
• Automated Annotation and Validation of Human Respiratory Virus Sequences using VADR

  2025cites this paper
• Discontinuous template switching generates coronavirus subgenomic RNAs from the 3ʹ viral genome end by 5ʹ to 3ʹ transcription

  2025cites this paper
• A Dual-Reporter HCoV-OC43 for Coronavirus Biology and Countermeasure Development.

  2025cites this paper
• Rapid generation of HCoV-229E and HCoV-OC43 reporter viruses and replicons for antiviral research

  2025cites this paper
• Automated annotation and validation of human respiratory virus sequences using VADR

  2025cites this paper
• Advances in the development of infectious clones of human coronaviruses and related applications

  2025cites this paper
• Human Betacoronavirus OC43 Interferes with the Integrated Stress Response Pathway in Infected Cells

  2024cites this paper
• Investigation of the Chemiluminescent Reaction of a Fluorinated Analog of Marine Coelenterazine

  2024cites this paper
• Design, synthesis, and antiviral activity of 1-aryl-4-arylmethylpiperazine derivatives as Zika virus inhibitors with broad antiviral spectrum.

  2024cites this paper
• Repurposing Drugs and Synergistic Combinations as Potential Therapies for Inhibiting SARS-CoV-2 and Coronavirus Replication.

  2024cites this paper
• Rapid generation and characterization of recombinant HCoV-OC43-VR1558 infectious clones expressing reporter Renilla luciferase

  2024influential citation
• Lycorine derivative effectively inhibits the replication of coronaviruses both in vitro and in vivo

  2023cites this paper
• Human Coronavirus OC43 as a Low-Risk Model to Study COVID-19

  2023cites this paper
• Establishment of a screening platform based on human coronavirus OC43 for the identification of microbial natural products with antiviral activity

  2023cites this paper
• Arbidol increases the survival rate by mitigating inflammation in suckling mice infected with human coronavirus OC43 virus

  2023cites this paper
• A nano-luciferase expressing human coronavirus OC43 for countermeasure development

  2023cites this paper
• An Overview of the Approaches for the Pharmacotherapy of Pandemic Causing Coronaviruses of the 21st Century

  2022cites this paper
• Rapid Assessment of Biological Activity of Ag-Based Antiviral Coatings for the Treatment of Textile Fabrics Used in Protective Equipment Against Coronavirus.

  2022cites this paper
• Construction and Generation of a Recombinant Senecavirus a Stably Expressing the NanoLuc Luciferase for Quantitative Antiviral Assay

  2021cites this paper
• Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside

  2021cites this paper
• Antimalarial drugs—are they beneficial in rheumatic and viral diseases?—considerations in COVID-19 pandemic

  2021cites this paper
• Discovery and optimization of 2-((1H-indol-3-yl)thio)-N-benzyl-acetamides as novel SARS-CoV-2 RdRp inhibitors

  2021cites this paper
• Pathomechanisms, therapeutic targets and potent inhibitors of some beta-coronaviruses from bench-to-bedside

  2021cites this paper
• The situation of small molecules targeting key proteins to combat SARS-CoV-2: Synthesis, metabolic pathway, mechanism of action, and potential therapeutic applications.

  2021cites this paper
• Applications of bioluminescence in biotechnology and beyond.

  2021cites this paper
• Therapeutic Preferences for Coronavirus 2(SARS-CoV-2) Patients

  2020cites this paper
• New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

  2020cites this paper
• Potentially repurposing adamantanes for COVID‐19

  2020cites this paper
• Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment

  2020cites this paper
• Battling COVID-19: using old weapons for a new enemy

  2020cites this paper
• Obstetric Management of COVID-19 in Pregnant Women

  2020cites this paper
• Chloroquine Administration in Breastfeeding Mothers Associates with Increased HIV-1 Plasma Viral Loads

  2020cites this paper
• Overcoming nonstructural protein 15-nidoviral uridylate-specific endoribonuclease (nsp15/NendoU) activity of SARS-CoV-2

  2020cites this paper
• A Systematic Literature Review of Current Therapeutic Approaches for COVID-19 Patients

  2020cites this paper
• Current Challenges of the 2019-COVID Pandemic: Where We Started, Where We Are, and Where do We Go?

  2020cites this paper
• Facts and myths: Efficacies of repurposing chloroquine and hydroxychloroquine for the treatment of COVID-19.

  2020cites this paper
• A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?

  2020cites this paper
• Inhibiting fusion with cellular membrane system: therapeutic options to prevent severe acute respiratory syndrome coronavirus-2 infection

  2020cites this paper
• Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?

  2020cites this paper
• A Pediatric Infectious Disease Perspective of SARS-CoV-2 and COVID-19 in Children.

  2020cites this paper
• Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2

  2020cites this paper
• Potential Antiviral Effect of Chloroquine Therapy against SARS-CoV-2 Infection

  2020cites this paper
• Assessing Preventive Effects of Chloroquine or Hydroxychloroquine againstCOVID-19: What is the Rationale and what Clinical Trials are Running?

  2020cites this paper
• Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses

  2020cites this paper
• A Pediatric Infectious Diseases Perspective of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Novel Coronavirus Disease 2019 (COVID-19) in Children

  2020cites this paper
• The treatment of SARS-CoV2 with Antivirals and Mitigation of the Cytokine Storm Syndrome: the role of gene expression.

  2020cites this paper
• Review of infective dose, routes of transmission, and outcome of COVID-19 caused by the SARS-COV2 virus: comparison with other respiratory viruses Running title: COVID-19 infective dose review

  2020cites this paper
• Broad-spectrum coronavirus antiviral drug discovery

  2019cites this paper
• Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?

  2019cites this paper
• Non-invasive bioluminescence imaging of HCoV-OC43 infection and therapy in the central nervous system of live mice

  2019cites this paper
• Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase

  2019cites this paper
• High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses

  2019cites this paper